Health In Tech director granted 18,867 shares

Hayes Timothy reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hayes Timothy reported acquisition or exercise transactions in this Form 4 filing.

Health In Tech, Inc. director Hayes Timothy received a grant of 18,867 restricted shares of Class A Common Stock at $1.06 per share under the Health in Tech Equity Incentive Plan. The restricted stock vested as of the grant date, bringing his direct holdings to 138,510 shares.

Insider Trade Summary

Grant/Award: 18,867 shares

Grant/Award 1 txn

Insider Hayes Timothy

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1	18,867	$1.06	$20K

Holdings After Transaction: Class A Common Stock — 138,510 shares (Direct)

Footnotes (1)

1. F1. Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Key Figures

Restricted shares granted: 18,867 shares Grant price per share: $1.06 Shares held after transaction: 138,510 shares

3 metrics

Restricted shares granted 18,867 shares Restricted Class A Common Stock granted to Hayes Timothy on 2026-07-08

Grant price per share $1.06 Transaction price per share for the restricted stock award

Shares held after transaction 138,510 shares Total direct holdings of Hayes Timothy following the grant

Key Terms

restricted shares, Equity Incentive Plan, Class A Common Stock

3 terms

restricted shares financial

"Represents restricted shares of Class A Common Stock granted to the reporting person"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Equity Incentive Plan financial

"granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

Class A Common Stock financial

"Represents restricted shares of Class A Common Stock granted to the reporting person"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Health In Tech (HIT) director Hayes Timothy report in this Form 4?

Hayes Timothy reported a grant of 18,867 restricted shares of Class A Common Stock. These shares were awarded under the Health in Tech Equity Incentive Plan and vested as of the grant date.

How many Health In Tech (HIT) shares does Hayes Timothy hold after this transaction?

After the reported award, Hayes Timothy directly holds 138,510 shares of Health In Tech Class A Common Stock. This figure reflects his position following the vesting of the restricted stock grant.

Was the Health In Tech (HIT) Form 4 transaction a market purchase or sale?

No. The Form 4 reports an award of restricted shares, coded as a grant (A), not an open-market purchase or sale. It represents equity compensation granted to the director, which vested immediately.

What was the value per share for the Health In Tech (HIT) restricted stock grant?

The restricted stock grant to Hayes Timothy used a value of $1.06 per share. This price is disclosed as the transaction price per share associated with the 18,867 restricted shares awarded.

Under which plan was the Health In Tech (HIT) restricted stock granted to Hayes Timothy?

The 18,867 restricted shares were granted under the Health in Tech Equity Incentive Plan. The filing states that these shares of restricted stock vested as of their grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/10/2026 - 06:45 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hayes Timothy

(Last) (First) (Middle)

701 S. COLORADO AVE

SUITE 1

(Street)

STUART FLORIDA 34994

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	07/08/2026		A		18,867(1)	A	$1.06	138,510	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Timothy Hayes	07/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)